• Meropenem: β-Lactam Antibiotic Carbapenem for Resistance Mod

  2026-04-21

  Meropenem is an ultra-broad-spectrum β-lactam antibiotic carbapenem with robust activity against both Gram-negative and Gram-positive bacteria. It targets penicillin-binding proteins to inhibit bacterial cell wall synthesis, making it essential in research on multidrug resistance and septicemia models. This article provides atomic, verifiable data on Meropenem’s mechanisms, resistance benchmarks, and protocol integration.

• Targeted Nanomedicine Strategy for Abdominal Aortic Aneurysm

  2026-04-20

  This study introduces a precision drug delivery system using tea polyphenol nanoparticles modified with cRGD for targeted doxycycline release in abdominal aortic aneurysm (AAA) lesions. By addressing multiple pathological mechanisms, the multifunctional nanocarrier demonstrates enhanced lesion targeting, reduced systemic toxicity, and significant promise for advancing pharmaceutical AAA therapy.

• One-step TUNEL Cy3 Apoptosis Detection Kit: Applied Workflow

  2026-04-20

  Harness the power of sensitive, Cy3-based DNA fragmentation detection across tissue and cell models using the One-step TUNEL Cy3 Apoptosis Detection Kit. This guide delivers actionable protocols, advanced troubleshooting, and translational strategies informed by recent breakthroughs in programmed cell death research.

• CTCF Ensures Centromere Integrity and Mitotic Fidelity in Hu

  2026-04-19

  This study reveals that CTCF, a chromatin-looping protein, is crucial for centromere maintenance and accurate mitotic division. Using rapid, inducible degradation in human cells, the authors show that loss of CTCF disrupts centromere function, chromosome alignment, and post-mitotic nuclear morphology, offering new mechanistic insight for mitosis research.

• HotStart™ 2X Green qPCR Master Mix: Technical Use and QC Gui

  2026-04-18

  HotStart™ 2X Green qPCR Master Mix is engineered to address specificity and reproducibility challenges in real-time PCR gene expression analysis and nucleic acid quantification. This reagent is best used for applications requiring SYBR Green-based detection with minimized non-specific amplification, but is not intended for probe-based qPCR or situations requiring multiplex detection of multiple targets in one well.

• Vancomycin Hydrochloride in Selective Media and Diagnostic I

  2026-04-17

  Explore the critical role of Vancomycin hydrochloride as a glycopeptide antibacterial agent in advanced diagnostic media, with a unique focus on its impact in veterinary pathogen research and assay design. This article delivers scientific depth beyond standard applications and highlights evidence from seminal studies.

• Guanabenz Acetate: Selective α2-Adrenergic Receptor Agonist

  2026-04-16

  Guanabenz Acetate is a potent, selective α2-adrenergic receptor agonist. It is widely used in neuroscience receptor research and GPCR signaling studies due to its high purity and robust subtype selectivity. APExBIO provides Guanabenz Acetate with validated quality metrics for consistent research use.

• AI Analysis of Urine Stem Cell Mitochondria as Alzheimer's B

  2026-04-15

  A recent study developed a deep learning workflow to non-invasively analyze mitochondrial morphology in urine-derived stem cells, distinguishing Alzheimer’s disease patients from controls. This approach highlights systemic mitochondrial dysfunction in AD and provides a foundation for accessible, dynamic biomarker discovery.

• Pomalidomide (CC-4047): Advanced Workflows for Myeloma Resea

  2026-04-14

  Pomalidomide (CC-4047) is transforming hematological malignancy research with its dual action on tumor cells and the microenvironment. This guide offers detailed protocols, troubleshooting insights, and evidence-backed applications for maximizing experimental success with CC-4047.

• TRPV1+ Nerve Stimulation Suppresses Inflammation via Somatoa

  2026-04-13

  Song et al. (2025) reveal that targeted stimulation of TRPV1+ peripheral somatosensory nerves can rapidly suppress systemic inflammation by activating a neural reflex connecting sensory input, brainstem nuclei, and autonomic outflow. This work clarifies the mechanistic basis for neuroimmune modulation and highlights the potential for TRPV1 agonists, such as Nonivamide, in inflammation research.

• Patient-Derived Gastric Cancer Assembloids Reveal Drug Respo

  2026-04-12

  This study introduces a patient-derived gastric cancer assembloid model integrating matched tumor organoids with stromal cell subpopulations, closely mirroring primary tumor heterogeneity. The model demonstrates how stromal components modulate gene expression and alter drug sensitivity, offering a robust platform for investigating tumor–stroma interactions and refining personalized therapeutic strategies.

• Sulfaphenazole: Precision CYP2C9 Inhibitor for Translational

  2026-04-12

  Sulfaphenazole empowers researchers with selective CYP2C9 inhibition, robust anti-tuberculosis activity, and proven vascular applications. Learn how to leverage its unique capabilities for drug metabolism, cell function, and antibacterial workflows—plus troubleshoot solubility and optimize assay performance with evidence-backed guidance.

• FITC Goat Anti-Mouse IgG (H+L): Application & Protocol Guida

  2026-04-11

  The FITC Goat Anti-Mouse IgG (H+L) Antibody enables sensitive detection of mouse IgG primary antibodies in immunofluorescence and flow cytometry, addressing challenges in signal amplification and assay specificity. It is unsuitable for applications requiring detection of non-mouse IgG or in workflows incompatible with FITC-based fluorescence.

• Concanamycin A: Precision V-type H+-ATPase Inhibitor in Canc

  2026-04-11

  Concanamycin A empowers cancer researchers with nanomolar-scale, reproducible V-type H+-ATPase inhibition, enabling rigorous dissection of endosomal acidification and apoptosis in tumor models. This guide details advanced workflows, troubleshooting, and protocol enhancements that leverage APExBIO’s Concanamycin A for next-generation cancer biology studies.

• SU6656 Src Tyrosine Kinases Inhibitor: Protocols & Transl...

  2026-04-10

  The SU6656 Src tyrosine kinases inhibitor empowers researchers to achieve precise modulation of Src signaling in both cancer research and stem cell differentiation workflows. Its unique ability to enhance polyploidization in megakaryocyte induction and sensitize tumor vasculature to radiotherapy sets it apart as an indispensable tool for translational science. Discover stepwise protocols, troubleshooting insights, and advanced use-cases that showcase how APExBIO's SU6656 (SKU B5839) accelerates innovation.

453 records 21/31 page Previous Next First page 上5页 2122232425 下5页 Last page